Overcome Biosafety Challenges With An Innovative Institutional Biosafety Committee (IBC)

Advancing innovative therapies requires a rigorous yet efficient approach to biosafety oversight. The Univo Institutional Biosafety Committee (IBC) is designed to protect researchers and the environment while simplifying the complexities of regulatory compliance. By aligning with NIH guidelines, the committee provides a secure framework for preclinical, translational, and advanced therapeutic studies, ensuring that safety remains paramount throughout the research lifecycle.

To accelerate study startup, Univo leverages internal communication between its IRB and IBC, removing the friction often found in fragmented submission processes. This client-first model includes a single point of contact and innovative platforms for real-time progress tracking, allowing sponsors to focus on clinical breakthroughs rather than administrative delays. Whether you need a full review or advisory services to establish a local committee, these solutions offer the specialized expertise necessary to navigate the modern biosafety landscape with confidence.